Development and characterization of gels and liposomes containing ovalbumin for nasal delivery Nasal delivery is an emerging strategy to prevent both local and systemic diseases. The aim of this study was to develop a promising and innovative therapeutic system for the nasal delivery system of liposomes. Ovalbumin(OVA) was used as a model compound in this study. https://www.sciencedirect.com/science/article/abs/pii/S1773224717305543
Search term:"ovalbumin virosome" Merck
vaccine bioprocessing handbook (1 MB) vaccine bioprocessing handbook The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. Table of Contents 2 The SAFC ® portfolio offers customized and ready-to-use raw material solutions, backed by deep regulatory expertise. Our high-quality prod...
Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating ... onlinelibrary.wiley.com › doi › full Dec 26, 2017 · Originally, passive encapsulation was used to generate protein- or peptide-carrying influenza virosomes. 16, 17 However, only approximately 225 ovalbumin (OVA) molecules could be encapsulated per virosomal particle using this technique. 16 In contrast, we estimate that one particle of DOGS-NTA-Ni-containing virosomes could conjugate . https://onlinelibrary.wiley.com/doi/full/10.1002/biot.201700645